At SXSW in Austin this weekend, consumer genomics company 23andMe unveiled its latest test, a predisposition report on Type 2 diabetes. The test, which has not undergone FDA clearance and does not ...
If your estate plan was created before the DNA testing era—or hasn't been updated to account for these new realities—now is the time to revisit it with qualified legal counsel. Because in 2025, a $99 ...
The FDA authorized 23andMe to market its pharmacogenetic report Oct. 31, marking the agency’s first time greenlighting a direct-to-consumer DNA test for this purpose. Pharmacogenetics is an area of ...
Anne Wojcicki, CEO and co-founder of 23andMe, fired back at critics who argue patients must work with physicians to interpret direct-to-consumer genetic test results. Ms. Wojcicki’s op-ed, published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results